These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 22664470

  • 1. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
    Babar M, Ryan AW, Anderson LA, Segurado R, Turner G, Murray LJ, Murphy SJ, Johnston BT, Comber H, Reynolds JV, McManus R.
    Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
    [Abstract] [Full Text] [Related]

  • 2. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
    Izakovicova Holla L, Borilova Linhartova P, Hrdlickova B, Marek F, Dolina J, Rihak V, Kala Z.
    Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
    [Abstract] [Full Text] [Related]

  • 3. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.
    Murphy SJ, Hughes AE, Patterson CC, Anderson LA, Watson RG, Johnston BT, Comber H, McGuigan J, Reynolds JV, Murray LJ.
    Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236
    [Abstract] [Full Text] [Related]

  • 4. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
    Menke V, Van Zoest KP, Moons LM, Pot RG, Siersema PD, Kuipers EJ, Kusters JG.
    Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson RG, McGuigan J, Reynolds JV, Hardie LJ.
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson RG, McGuigan J, Reynolds JV, Hardie LJ.
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence.
    McElholm AR, McKnight AJ, Patterson CC, Johnston BT, Hardie LJ, Murray LJ, Finbar Group.
    Gastroenterology; 2010 Jul; 139(1):204-12.e3. PubMed ID: 20403354
    [Abstract] [Full Text] [Related]

  • 10. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.
    Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, Krishnadath KK, Bergman JJ, van Vliet AH, Siersema PD, Kusters JG.
    Am J Gastroenterol; 2007 Nov; 102(11):2373-9. PubMed ID: 17581270
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?
    Gough MD, Ackroyd R, Majeed AW, Bird NC.
    Am J Gastroenterol; 2005 May; 100(5):1012-8. PubMed ID: 15842572
    [Abstract] [Full Text] [Related]

  • 13. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
    Rajendra S, Wang B, Snow ET, Sharma P, Pavey D, Merrett N, Ball MJ, Brain T, Fernando R, Robertson IK.
    Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
    [Abstract] [Full Text] [Related]

  • 14. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [Abstract] [Full Text] [Related]

  • 15. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM, Li Y, Wang N, Zhang XJ, Dong XJ, Guo W.
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
    Wei YS, Lan Y, Liu YG, Tang H, Tang RG, Wang JC.
    Acta Oncol; 2007 Sep; 46(8):1090-6. PubMed ID: 17851835
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [Abstract] [Full Text] [Related]

  • 19. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].
    Zhang PA, Wu JM, Li Y, Yang XS.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
    Casson AG, Zheng Z, Evans SC, Geldenhuys L, van Zanten SV, Veugelers PJ, Porter GA, Guernsey DL.
    Cancer; 2005 Aug 15; 104(4):730-9. PubMed ID: 15971196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.